The HLH-2004 diagnostic criteria
Criteria for when to suspect HLH
Persistent fever
Low or absent NK-cell activity
High sCD25 ≥2400 U/mL
Splenomegaly
High ferritin ≥500 µg/L
Hemophagocytosis*
Cytopenia
(affecting ≥2 of 3 lineages in the peripheral blood)
- Hemoglobin <90 g/L (in infants <4 weeks: hemoglobin <100 g/L)
- Platelets <100 x 109/L
- Neutrophils <1.0 x 109/L
Hypertriglyceridemia and/or hypofibrinogenemia
- Fasting triglycerides ≥3.0 mmol/L (ie, ≥265 mg/dL)
- Fibrinogen ≤1.5 g/L
NK=natural killer; sCD25=soluble interleukin-2 receptor.
*Hemophagocytosis is not specific nor always present in early stages of the disease.2
How were these criteria developed?
The HLH-2004 criteria were originally developed as inclusion criteria for a clinical study about HLH. Because the presentation of HLH can vary widely from patient to patient, there are some limitations with this criteria.3 For more information on other testing that can be conducted to help confirm or rule out an HLH diagnosis, visit the genetic testing and flow cytometry and ancillary testing pages.
It is also important to rule out any underlying cause such as malignancy, especially lymphoma, or viral infection.3
References: 1. Henter JI, Horne A, Aricó M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124-131. doi:10.1002/pbc.21039 2. Jordan MB, Allen CE, Weitzman S, Filipovich AH, McClain KL. How I treat hemophagocytic lymphohistiocytosis. Blood. 2011;118(15):4041-4052. doi:10.1182/blood-2011-03-278127 3. Jordan MB, Allen CE, Greenberg J, et al. Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: recommendations from the North American Consortium for Histiocytosis (NACHO). Pediatr Blood Cancer. 2019;66(11):e27929. doi:10.1002/pbc.27929